PT - JOURNAL ARTICLE AU - Arsham Ghavasieh AU - Sebastiano Bontorin AU - Oriol Artime AU - Manlio De Domenico TI - Multiscale statistical physics of the Human–SARS-CoV-2 interactome AID - 10.1101/2020.09.06.20189266 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.06.20189266 4099 - http://medrxiv.org/content/early/2020/09/08/2020.09.06.20189266.short 4100 - http://medrxiv.org/content/early/2020/09/08/2020.09.06.20189266.full AB - Protein-protein interaction (PPI) networks have been used to investigate the influence of SARS-CoV-2 viral proteins on the function of human cells, laying out a deeper understanding of COVID–19 and providing ground for drug repurposing strategies. However, our knowledge of (dis)similarities between this one and other viral agents is still very limited. Here we compare the novel coronavirus PPI network against 45 known viruses, from the perspective of statistical physics. Our results show that classic analysis such as percolation is not sensitive to the distinguishing features of viruses, whereas the analysis of biochemical spreading patterns allows us to meaningfully categorize the viruses and quantitatively compare their impact on human proteins. Remarkably, when Gibbsian-like density matrices are used to represent each system’s state, the corresponding macroscopic statistical properties measured by the spectral entropy reveals the existence of clusters of viruses at multiple scales. Overall, our results indicate that SARS-CoV-2 exhibits similarities to viruses like SARS-CoV and Influenza A at small scales, while at larger scales it exhibits more similarities to viruses such as HIV1 and HTLV1.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll raw data used in this study are publicly available. Processed data are available upon request. https://string-db.org/cgi/download.pl https://downloads.thebiogrid.org/BioGRID/Release-Archive/BIOGRID-3.5.182/ ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/GENE_INFO/Mammalia/ http://viruses.string-db.org/